Hiroaki Mitsuya

Hiroaki Mitsuya (満屋 裕明, Mitsuya Hiroaki; born 1950) is a Japanese virologist famous for his role in discovery of the anti-HIV drug zidovudine (AZT) as well as other anti-AIDS drugs including didanosine (ddI) and zalcitabine (ddC).

Mitsuya was born in Sasebo, Nagasaki and received his M.D. and Ph.D. from Kumamoto University. He joined the American National Cancer Institute in Bethesda, Maryland, in 1982, working initially on Human T-lymphotropic virus 1 before switching his attention to HIV. His identification of AZT as an anti-HIV drug, as well as the anti-HIV properties of didanosine and zalcitabine, was made in 1985. He was appointed Professor of Hematology, Rheumatology and Clinical Immunology at Kumamoto University Graduate School of Medical And Pharmaceutical Sciences.

In December, 2006, he was awarded the first NIH World AIDS Day Award for his work in developing drugs for AIDS. Mitsuya has been chief of the NCI's Experimental Retrovirology Section since 1991.

Awards and honors

  1. ^ 2007年4月28日薬事日報
  2. ^ 第12回慶應医学賞受賞者
  3. ^ "満屋臨床研究センター長が「読売国際協力賞」を受賞しました". 国立健康危機管理研究機構臨床研究センター. 2014-11-18. Retrieved 2025-10-25. {{cite web}}: Text "和書" ignored (help)
  4. ^ 朝日賞　2014(平成26)年度　受賞者一覧
  5. ^ Cite error: The named reference jacad was invoked but never defined (see the help page).
  6. ^ Cite error: The named reference sportal was invoked but never defined (see the help page).
  7. ^ Cite error: The named reference nhk was invoked but never defined (see the help page).
  8. ^ 『官報』号外232号、令和5年11月6日
  9. ^ "秋の叙勲4075人 三浦友和さんや久石譲さんらに". 日本経済新聞. 2023-11-03. Retrieved 2023-11-17.
  10. ^ "王貞治氏ら8人に文化勲章 功労者に坂茂氏ら". The Nikkei (in Japanese). 18 October 2025. Retrieved 18 October 2025.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.